3 results
Approved WMOCompleted
To evaluate the safety and clinical utility of PEF treatment of advanced stage or metastatic cancer following progression on immunotherapy
Approved WMOWill not start
Primary Objective:* confirm the dose of nomacopan and sample size for Part B and evaluate the rank order of secondary endpointsOther Objectives:* compare nomacopan with adjunct OCS to placebo with adjunct OCS in achievement of Complete Remission of…
Approved WMOCompleted
To evaluate the safety and initial feasibility of PEF treatment of NSCLC tumors prior to surgical resection.